News

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

March 13, 2020 signalgroup

ICYMI: This Week, HHS Secretary Azar, Congressman Burgess, Physicians and Patients Pointed to Biosimilars to Save Seniors and Taxpayers Money; Congress Introduces Two Bills to Lower Costs with Biosimilars

March 13, 2020 signalgroup

The Biosimilars Forum Applauds Senators McSally (R-AZ) and Jones (D-AL) Introduction of S. 3466, the ACCESS for Biosimilars Act of 2020

March 11, 2020 signalgroup

The Biosimilars Forum Supports Congressmen Cardenas, Hudson, Fitzpatrick, & Craig Introduction of H.R. 6179 — Lowering Costs For Taxpayers and Medicare Seniors with Biosimilars

March 5, 2020 signalgroup

The Importance of Dispelling Misinformation About Biosimilar Therapies

February 10, 2020 signalgroup

White House Budget Proposal Recognizes Urgent Need to Increase Patient Access to Lower-Cost Biosimilars

February 4, 2020 signalgroup

President Trump Can Look to Biosimilars to Keep Promise of Saving Americans Billions in Health Care Costs

February 3, 2020 signalgroup

Biosimilars Forum Praises FTC and FDA Action to Fight Anticompetitive Behaviors Blocking Access to Lower Cost Biosimilars

December 12, 2019 signalgroup

Biosimilars Forum Statement on Policies Supporting Biosimilar Uptake in Canadian Market

December 12, 2019 signalgroup

Biosimilars Forum Congratulates Dr. Stephen Hahn on Confirmation to Lead the Food and Drug Administration (FDA)

November 25, 2019 signalgroup

ICYMI: Biosimilars are a Recognized, Bipartisan Solution to Lowering Health Care Costs; Nominee for FDA Commissioner Reinforces Need to Increase Access for Biosimilars